The results of this study indicate the anticancer activity of Caulerpa racemosa through anti-metastatic by significantly inhibiting the migration of HeLa cancer cells, reducing Snail as an inducer of the EMT process and the expression of the mesenchymal marker Vimentin, and significantly increasing the epithelial marker E-Cadherin. The gene discussed is SNAI1; the disease is cancer.